ArticleCanadian liver journal2026

Myosteatosis as a prognostic biomarker for post-transplant survival and cardiometabolic outcomes: A retrospective study.

Serena Bansal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.